1 code implementation • 9 Mar 2024 • R. Li, J. Liu, X. L. Deng, X. Liu, J. C. Guo, W. Y. Wu, L. Yang
The diagnosis and monitoring of Castrate Resistant Prostate Cancer (CRPC) are crucial for cancer patients, but the current models (such as P-NET) have limitations in terms of parameter count, generalization, and cost.
